The UK Medicines and Healthcare Regulatory Agency (MHRA)sum a la myelitis transversa as a secondary effect “extremely rare”associated with the AstraZeneca vaccine against coronavirus (COVID 19).
“The MHRA has continued to monitor reports of suspected transverse myelitis after vaccination against Covid-19 since the start of the program. As of January 19, 2022, 108 reports of suspected TM were received after administration”informed the local portal Health.detik.com.
From the entity they emphasized that beyond the preliminary results on “la manifestation with few probabilities of appearing”the consensus prevails that inoculation is the only effective measure against COVID 19.
“There are reports coming in, the numbers are very small, some are not related to immunization and all have fully recovered.”expanded the head of the National Commission for Adverse Events Post Immunization (Komnas KIPI), Hindra Irawan Satari.
COVID ALERT: a request to the population after the 40% increase in cases
Bill Gates predicted the new monkeypox: when did he say it and what warning did he give?
What is transverse myelitis, the rare side effect of the AstraZeneca vaccine
The transverse mielitis (TM) is a rare acute neurological disorder that affects the spinal cord. It may cause weakness in the arms or legs, sensory symptoms, or problems with bladder or bowel function.
What are the symptoms of transverse myelitis
The MHRA advised patients experiencing any type of episode of myelitis transversa after the first dose of AstraZeneca’s COVID-19 vaccine what “don’t get a follow-up dose”.
“An additional dose of Vaxzevria should not be given to those who have experienced symptoms of transverse myelitis after a previous dose of this vaccine”instruy.
COVID ALERT: vaccine by vaccine, the side effects of Pfizer, Moderna, AstraZeneca and all those that occur in Argentina
Long COVID: Do vaccines also reduce it? What do the latest studies say
Transverse myelitis, the rare side effect of the AstraZeneca vaccine: the history of the relationship
On January 15, a safety panel of the European medicines regulator (EMA) had listed the myelitis transversa as a side effect of AstraZeneca’s COVID-19 vaccine.
After reviewing the data, he concluded that there was a “possible causal relationship” between two doses of drugs, however they emphasized that it remains in a character “extremely rare”.
Bill Gates’ worrying forecast on the pandemic: “We haven’t even seen the worst”
Covid world alert: a new study revealed the estimated date on which the pandemic will end
–
